Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813442 | 12681344 | 2 | F | 20160607 | 20160912 | 20160824 | 20160926 | EXP | US-ACORDA-ACO_127218_2016 | ACORDA | 64.21 | YR | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813442 | 12681344 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | U | U | 22250 | 10 | MG | TABLET | Q12H | ||||
126813442 | 12681344 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | U | 22250 | 10 | MG | TABLET | BID | ||||
126813442 | 12681344 | 3 | C | TECFIDERA | DIMETHYL FUMARATE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126813442 | 12681344 | 1 | Multiple sclerosis |
126813442 | 12681344 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126813442 | 12681344 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126813442 | 12681344 | Fall | |
126813442 | 12681344 | Lower limb fracture | |
126813442 | 12681344 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126813442 | 12681344 | 1 | 201007 | 0 | ||
126813442 | 12681344 | 2 | 20140128 | 0 |